Beneficiary Profile: Victor Chang

Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. Every 12 minutes, one Australian dies from the disease. This is why the Victor Chang Cardiac Research Institute is dedicated to finding cures through their world class research.

Beneficiary Profile: Victor Chang

October 12, 2020
Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. Every 12 minutes, one Australian dies from the disease. This is why the Victor Chang Cardiac Research Institute is dedicated to finding cures through their world class research.
Read Transcript

Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. This is projected to increase to $22 billion over the next decade. Cardiovascular disease has reached pandemic proportions with one Australian dying from the disease every 12 minutes. This is why scientists and doctors at the Victor Chang Cardiac Research Institute, Australia’s home of heart research, are dedicated to finding cures through their world class research.   

2019 was a landmark year with the Victor Chang Cardiac Research Institute celebrating 25 years of scientific achievements.  Over the last 25 years, the Victor Chang Cardiac Research Institute has made a multitude of major advances in heart research, many revolutionising our understanding of disease causes, treatment, and prevention in the areas of heart attack, cholesterol, heart arrhythmia, cardiomyopathy, congenital heart disease and  genetic analysis.

A new era for the Institute began in March 2020 as they welcomed Professor Jason Kovacic. A highly respected cardiologist and researcher, Professor Kovacic relocated from Mount Sinai Hospital in New York to take the reins as the Executive Director of the Victor Chang Cardiac Research Institute, and is the inaugural Robert Graham Professor of Cardiovascular Research. Named in honour of the Institute’s Founding Executive Director, this prestigious Chair position is generously supported by HM1 and provides critical ongoing funding to foster scientific excellence for the Institute.

Helped by partners like HM1 and Magellan, the Institute’s Innovation centre is heralding a research revolution in our search to solve the unsolved. It is pushing the boundaries of knowledge by transforming the landscape of cardiovascular research around Australia and the Asia Pacific. The Institute’s world class technology is accelerating the opportunities of discovering cures for heart disease and bringing us closer to realising “personalised” medicine of the future and improving health outcomes for patients suffering from heart disease in Australia and around the world. 

As part of our impact video series, we spoke with Founding Executive Director Professor Robert Graham and Professor Sally Dunwoodie, Head of Embryology, discussing the importance of medical research and their recent breakthroughs. You can watch the video below:

 

Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. This is projected to increase to $22 billion over the next decade. Cardiovascular disease has reached pandemic proportions with one Australian dying from the disease every 12 minutes. This is why scientists and doctors at the Victor Chang Cardiac Research Institute, Australia’s home of heart research, are dedicated to finding cures through their world class research.   

2019 was a landmark year with the Victor Chang Cardiac Research Institute celebrating 25 years of scientific achievements.  Over the last 25 years, the Victor Chang Cardiac Research Institute has made a multitude of major advances in heart research, many revolutionising our understanding of disease causes, treatment, and prevention in the areas of heart attack, cholesterol, heart arrhythmia, cardiomyopathy, congenital heart disease and  genetic analysis.

A new era for the Institute began in March 2020 as they welcomed Professor Jason Kovacic. A highly respected cardiologist and researcher, Professor Kovacic relocated from Mount Sinai Hospital in New York to take the reins as the Executive Director of the Victor Chang Cardiac Research Institute, and is the inaugural Robert Graham Professor of Cardiovascular Research. Named in honour of the Institute’s Founding Executive Director, this prestigious Chair position is generously supported by HM1 and provides critical ongoing funding to foster scientific excellence for the Institute.

Helped by partners like HM1 and Magellan, the Institute’s Innovation centre is heralding a research revolution in our search to solve the unsolved. It is pushing the boundaries of knowledge by transforming the landscape of cardiovascular research around Australia and the Asia Pacific. The Institute’s world class technology is accelerating the opportunities of discovering cures for heart disease and bringing us closer to realising “personalised” medicine of the future and improving health outcomes for patients suffering from heart disease in Australia and around the world. 

As part of our impact video series, we spoke with Founding Executive Director Professor Robert Graham and Professor Sally Dunwoodie, Head of Embryology, discussing the importance of medical research and their recent breakthroughs. You can watch the video below:

 

Disclaimer: This material has been prepared by Victor Chang Cardiac Research Institute, published on Oct 12, 2020. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
September 23, 2021

Partnership with Swinburne & Cooper Investors

Swinburne has signed a transformational $1 million agreement with Hearts and Minds Investments Ltd and Cooper Investors supporting vital mental health medical research.

Read More
August 19, 2021

The Florey: Innovative new approach for Parkinson’s disease

Florey researchers have partnered with engineers from ANU to develop and study a new type of hydrogel that could radically transform a novel stem cell treatment for Parkinson’s disease.

Read More
August 10, 2021

Podcast: Minding Your Mind

Prof Ian Hickie, of the Brain and Mind Centre has launched a podcast, Minding Your Mind, to explore all aspects of mental health; the different types of mental health issues we can experience, their causes, how they affect us, and what we can do to get help and find solutions.

Read More
August 3, 2021

Australian breakthrough to stop heart arteries from clogging

Victor Chang scientist has led landmark research that has the potential to stop arteries of the heart from becoming clogged by targeting a particular gene.

Read More
July 16, 2021

Victor Chang: Discovery of live-saving heart attack treatment

New research out of Victor Chang brings treatment for Australia’s biggest killer a step closer, this exciting discovery could lead to new preventative treatments for atherosclerosis and coronary artery disease.

Read More
February 23, 2021

Podcast: Paul Rayson, Mental Wellth

This episode of Mental Wellth looks at how mental health is funded and Paul Rayson discusses how vehicles like Hearts and Minds are an emerging funding solution.

Read More
December 9, 2020

Beneficiary Profile: MS Research Australia

MS Research Australia is the largest non-government funder of research into multiple sclerosis (MS). They have invested over $44.3m into MS research via major collaborative research platforms and investigator-led projects.

Read More
November 23, 2020

Thank you from MS Research Australia

MS Research Australia has a message of thanks to the Hearts and Minds Community for the support we provide them and their research to Stop and Reverse MS within the next 10 years.

Read More
September 27, 2020

Thank you from Prof Pat McGorry, Orygen

Professor Pat McGorry, Executive Director of Orygen has a message of thanks to Cooper Investors and HM1 shareholders for the support we provide them and their research into the mental health of young people.

Read More
September 25, 2020

The ASX company championing hearts and minds

Swinburne’s Centre for Human Psychopharmacology is honoured to have been selected by one of Hearts and Minds’ fund managers, Cooper Investors, as a recipient of funding.

Read More
September 23, 2020

Silent wave' of brain damage could follow pandemic

Australia urgently needs to prepare for a "silent wave" of COVID-19, which appears to be taking the form of long-term neurological side effects following infection with the virus.

Read More
September 8, 2020

Beneficiary Profile: Black Dog Institute

1 in 5 of us will experience symptoms of mental illness in any given year. In Australia that’s around 5 million people. And roughly 60% of these people won’t seek help. Learn what Black Dog is doing to create a mentally healthier world for everyone.

Read More
September 1, 2020

ABC: Cash for Causes

An increasing number of LICs are being created to spit out cash for causes. HM1 is such a LIC that top fund managers donate their time too. This year it paid out $9.3m to medical research. HM1's Chairman Chris Cuffe, speaks to Elysse Morgan on ABC's The Business.

Read More
September 1, 2020

Hearts and Minds donates almost $10m to charity

Listed investment company Hearts and Minds Investments (ASX: HM1) will donate $5.1 million to 10 medical research this week, in addition to the $4.1 million it already donated in March. [Financial Standard]

Read More
September 1, 2020

Hearts and Minds keep shining the light on medical research

CEO Paul Rayson says HM1's results are outstanding given the bumpy period. COVID-19 has shone a light on medical research and he's proud to contribute to the field and help support people during these tough times.

Read More